| The dynamic interplay between AMPK/NFκB signaling and NLRP3 is a new therapeutic target in inflammation: Emerging role of dapagliflozin in overcoming lipopolysaccharide … EE Abd El-Fattah, S Saber, AAE Mourad, E El-Ahwany, NA Amin, ... Biomedicine & Pharmacotherapy 147, 112628, 2022 | 57 | 2022 |
| A Novel Combination Therapy Using Rosuvastatin and Lactobacillus Combats Dextran Sodium Sulfate-Induced Colitis in High-Fat Diet-Fed Rats by Targeting the … S Saber, EE Abd El-Fattah, G Yahya, NA Gobba, AO Maghmomeh, ... Pharmaceuticals 14 (4), 341, 2021 | 53 | 2021 |
| Novel potent and selective DPP-4 inhibitors: Design, synthesis and molecular docking study of dihydropyrimidine phthalimide hybrids AAE Mourad, AE Khodir, S Saber, MAE Mourad Pharmaceuticals 14 (2), 144, 2021 | 45 | 2021 |
| Albendazole-loaded cubosomes interrupt the ERK1/2-HIF-1α-p300/CREB axis in mice intoxicated with diethylnitrosamine: A new paradigm in drug repurposing for the inhibition of … Biomedicine & Pharmacotherapy 142, 1-14, 2021 | 41* | 2021 |
| Ambroxol, a mucolytic agent, boosts HO‐1, suppresses NF‐κB, and decreases the susceptibility of the inflamed rat colon to apoptosis: A new treatment option for treating … S Cavalu, H Sharaf, S Saber, ME Youssef, AM Abdelhamid, AAE Mourad, ... The FASEB Journal 36 (9), e22496, 2022 | 33 | 2022 |
| AKT-AMPKα-mTOR-dependent HIF-1α activation is a new therapeutic target for cancer treatment: a novel approach to repositioning the antidiabetic drug sitagliptin for the … EE Abd El-Fattah, S Saber, ME Youssef, H Eissa, E El-Ahwany, NA Amin, ... Frontiers in Pharmacology 12, 720173, 2022 | 33 | 2022 |
| Novel HDAC/tubulin dual inhibitor: Design, synthesis and docking studies of α-phthalimido-chalcone hybrids as potential anticancer agents with apoptosis-inducing activity AAE Mourad, MAE Mourad, PG Jones Drug Design, Development and Therapy, 3111-3130, 2020 | 32 | 2020 |
| Coomassie brilliant blue G-250 dye attenuates bleomycin-induced lung fibrosis by regulating the NF-κB and NLRP3 crosstalk: A novel approach for filling an unmet medical need MH Zohny, S Cavalu, ME Youssef, MMY Kaddah, AAE Mourad, ... Biomedicine & Pharmacotherapy 148, 112723, 2022 | 30 | 2022 |
| Design, synthesis, cytotoxic screening and molecular docking studies of novel hybrid thiosemicarbazone derivatives as anticancer agents FZ Mohammed, YW Rizzk, IM El Deen, AAE Mourad, M El Behery Chemistry & Biodiversity 18 (12), e2100580, 2021 | 26 | 2021 |
| Innovative challenge for the inhibition of hepatocellular carcinoma progression by combined targeting of HSP90 and STAT3/HIF-1α signaling S Saber, EE Abd El-Fattah, AM Abdelhamid, AAE Mourad, ... Biomedicine & Pharmacotherapy 158, 114196, 2023 | 23 | 2023 |
| Nifuroxazide-loaded cubosomes exhibit an advancement in pulmonary delivery and attenuate bleomycin-induced lung fibrosis by regulating the STAT3 and NF-κB signaling: A new … S Saber, M Nasr, MMY Kaddah, G Mostafa-Hedeab, S Cavalu, ... Biomedicine & Pharmacotherapy 148, 112731, 2022 | 23 | 2022 |
| Novel topoisomerase II/EGFR dual inhibitors: design, synthesis and docking studies of naphtho[2′,3′:4,5]thiazolo[3,2-a]pyrimidine hybrids as potential anticancer … MAE Mourad, A Abo Elmaaty, I Zaki, AAE Mourad, A Hofni, AE Khodir, ... Journal of Enzyme Inhibition and Medicinal Chemistry 38 (1), 2205043, 2023 | 20 | 2023 |
| EGFR/VEGFR-2 dual inhibitor and apoptotic inducer: Design, synthesis, anticancer activity and docking study of new 2-thioxoimidazolidin-4one derivatives AAE Mourad, NA Farouk, ESH El-Sayed, ARE Mahdy Life Sciences 277, 119531, 2021 | 19 | 2021 |
| Synthesis and Cytotoxicity Screening of Some Synthesized Hybrid Nitrogen Molecules as Anticancer Agents MEB Ahmed A.E. Mourad , Youstina W. Rizzk , Islam Zaki , Faten Z. Mohammed Journal of Molecular Structure, 2021 | 19 | 2021 |
| Comparative study between atorvastatin and losartan on high fat diet‐induced type 2 diabetes mellitus in rats AA Mourad, GH Heeba, A Taye, MA El‐Moselhy Fundamental & clinical pharmacology 27 (5), 489-497, 2013 | 19 | 2013 |
| Protective effects of mirazid on gentamicin-induced nephrotoxicity in rats through antioxidant, anti-inflammatory, JNK1/iNOS, and apoptotic pathways; novel mechanistic insights S Antar, AA Al-Karmalawy, A Mourad, M Mourad, M Elbadry, S Saber, ... Pharmaceutical Sciences 28 (4), 525-540, 2022 | 14 | 2022 |
| Design and synthesis of novel pyrazolopyrimidine candidates as promising EGFR-T790M inhibitors and apoptosis inducers AA Gaber, M Sharaky, AA Elmaaty, MM Hammouda, AAE Mourad, ... Future Medicinal Chemistry 15 (19), 1773-1790, 2023 | 11 | 2023 |
| Glycerol 85% efficacy on atopic skin and its microbiome: a randomized controlled trial with clinical and bacteriological evaluation R Youssef, V Hafez, Y Elkholy, A Mourad Journal of Dermatological Treatment 32 (7), 730-736, 2021 | 10 | 2021 |
| Adipogenetic effects of retrofractamide A derivatives in 3T3-L1 cells AAF Mourad, S Nakamura, T Ueno, T Minami, T Yagi, H Yasue, ... Bioorganic & medicinal chemistry letters 23 (17), 4813-4816, 2013 | 10 | 2013 |
| New pyrazole-clubbed pyrimidine or pyrazoline hybrids as anti-methicillin-resistant Staphylococcus aureus agents: design, synthesis, in vitro and in vivo evaluation, and … B Mansour, MA El-Sherbeny, FAM Al-Omary, S Saber, HA Ramadan, ... ACS omega 8 (46), 44250-44264, 2023 | 7 | 2023 |
